Recursion Pharmaceuticals Faces Cash Burn and Pipeline Uncertainty Amid Partnership Milestones
Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) has turned its AI‑driven discovery engine into a double‑edged sword: w...
Read story →
Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) has turned its AI‑driven discovery engine into a double‑edged sword: w...
Read story →
On July 28, Saudi Basic Industries Corp. (SABIC) announced that its board of directors has approved a cash dividend of S...
Read story →
Aduro Clean Technologies Inc. (Nasdaq: ADUR, CSE: ACT) announced on June 17, 2026 that it has signed a memorandum of und...
Read story →